Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares RepurchasedShort-Term Debt repayments
Ratios

Ani Pharmaceuticals (ANIP) Shares Repurchased (2021 - 2025)

Ani Pharmaceuticals' Shares Repurchased history spans 9 years, with the latest figure at $611000.0 for Q4 2025.

  • For Q4 2025, Shares Repurchased rose 92.14% year-over-year to $611000.0; the TTM value through Dec 2025 reached $12.2 million, up 11.41%, while the annual FY2025 figure was $12.2 million, 11.41% up from the prior year.
  • Shares Repurchased for Q4 2025 was $611000.0 at Ani Pharmaceuticals, down from $1.0 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $10.0 million in Q1 2025 and bottomed at $1000.0 in Q4 2021.
  • The 5-year median for Shares Repurchased is $544000.0 (2023), against an average of $1.6 million.
  • The largest annual shift saw Shares Repurchased skyrocketed 11800.0% in 2022 before it crashed 57.62% in 2025.
  • A 5-year view of Shares Repurchased shows it stood at $1000.0 in 2021, then surged by 11800.0% to $119000.0 in 2022, then soared by 94.12% to $231000.0 in 2023, then soared by 37.66% to $318000.0 in 2024, then skyrocketed by 92.14% to $611000.0 in 2025.
  • Per Business Quant, the three most recent readings for ANIP's Shares Repurchased are $611000.0 (Q4 2025), $1.0 million (Q3 2025), and $551000.0 (Q2 2025).